Alanine catabolism as a targetable vulnerability for MYC-driven liver cancer.

Montoya et al. uncover a role for alanine as a conserved metabolic substrate for MYC-driven liver cancer. GPT2 is a therapeutic target for MYC-overexpressing liver tumors.